MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
23.83
+0.43
+1.82%
Opening 11:12 05/14 EDT
OPEN
23.42
PREV CLOSE
23.40
HIGH
24.19
LOW
23.42
VOLUME
154.02K
TURNOVER
0
52 WEEK HIGH
31.67
52 WEEK LOW
11.16
MARKET CAP
1.10B
P/E (TTM)
-10.4881
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PCRX last week (0505-0509)?
Weekly Report · 2d ago
Pacira BioSciences First Quarter 2025 Earnings: Misses Expectations
Simply Wall St · 4d ago
Pacira’s Earnings Call Highlights Strategic Wins and Growth
TipRanks · 4d ago
Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
NASDAQ · 5d ago
Where Pacira BioSciences Stands With Analysts
Benzinga · 5d ago
Pacira BioSciences Price Target Cut to $30.00/Share From $32.00 by Needham
Dow Jones · 5d ago
Pacira BioSciences Is Maintained at Buy by Needham
Dow Jones · 5d ago
Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $30
Benzinga · 5d ago
More
About PCRX
More
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.
Recently
Symbol
Price
%Change

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.